166
Participants
Start Date
June 20, 2022
Primary Completion Date
May 30, 2024
Study Completion Date
October 15, 2024
lerodalcibep
300 mg
Inclisiran
284 mg
The Lipid Clinic (Oslo University Hospital), Oslo
Hopitaux de Marseille, Marseille
CHU de Nantes - Hôpital Nord Laennec, Nantes
Hospital Universitario Miguel Servet, Zaragoza
Universitätsklinikum Heidelberg - Medizinische Klinik, Heidelberg
Oak Tree Surgery and Pensilva Health Centre, Liskeard
Ashton Medical Group, Ashton-under-Lyne
Lead Sponsor
Collaborators (1)
Medpace, Inc.
INDUSTRY
LIB Therapeutics LLC
INDUSTRY